Brief: Funicular Funds, Lp Reports 9.99% Passive Stake In Calidi Biotherapeutics As Of September 4- SEC Filing
Calidi Biotherapeutics Inc CLDI.A :
* FUNICULAR FUNDS, LP REPORTS 9.99% PASSIVE STAKE IN CALIDI
BIOTHERAPEUTICS AS OF SEPTEMBER 4- SEC FILING
Source text for Eikon: ID:n0001937147-24-000008
Further company coverage: CLDI.A
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma